Psoriatic arthritis: a systematic review
Identifieur interne : 006412 ( Istex/Corpus ); précédent : 006411; suivant : 006413Psoriatic arthritis: a systematic review
Auteurs : Fabrizio Cantini ; Laura Niccoli ; Carlotta Nannini ; Olga Kaloudi ; Michele Bertoni ; Emanuele CassaràSource :
- International Journal of Rheumatic Diseases [ 1756-1841 ] ; 2010-10.
Abstract
Psoriatic arthritis is an inflammatory rheumatic disorder of unknown etiology occurring in patients with psoriasis. The Classification Criteria for Psoriatic Arthritis study group has recently developed a validated set of classification criteria for psoriatic arthritis with a sensitivity of 91.4% and a specificity of 98.7%. Three main clinical patterns have been identified: oligoarticular (≤ 4 involved joints) or polyarticular (≥ 5 involved joints) peripheral disease and axial disease with or without associated peripheral arthritis. In this context distal interphalangeal arthritis and arthritis mutilans may occur. According to other reports, also in our centre, asymmetric oligoarthritis is the most frequent pattern at onset. Axial disease has been estimated between 5% and 36% of patients. It is characterized by an irregular involvement of the axial skeleton with a predilection for the cervical spine. Recurrent episodes of enthesitis and dactylitis represent a hallmark of psoriatic arthritis. In around 20% of cases distal extremity swelling with pitting edema of the hands or feet is observed. Unilateral acute iridocyclitis, usually recurrent in alternate fashion, is the most frequent extra‐articular manifestation, and accelerated atherosclerosis is the prominent comorbidity. The clinical course of peripheral and axial psoriatic arthritis is usually less severe than rheumatoid arthritis and ankylosing spondylitis, respectively. Local corticosteroid injections and non‐steroidal anti‐inflammatory drugs are recommended in milder forms. Sulphasalazine and methotrexate are effective in peripheral psoriatic arthritis. Recent studies have provided evidence on the efficacy of anti‐tumor necrosis factor‐α drugs to control symptoms and to slow or arrest radiological disease progression.
Url:
DOI: 10.1111/j.1756-185X.2010.01540.x
Links to Exploration step
ISTEX:D5994C6B4CA7C198E4159348AC0F09AAC38EAD6ELe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Psoriatic arthritis: a systematic review</title><author><name sortKey="Cantini, Fabrizio" sort="Cantini, Fabrizio" uniqKey="Cantini F" first="Fabrizio" last="Cantini">Fabrizio Cantini</name><affiliation><mods:affiliation>2nd Department of Internal Medicine, Rheumatology Unit, Hospital Misericordia e Dolce, Prato, Italy</mods:affiliation></affiliation></author><author><name sortKey="Niccoli, Laura" sort="Niccoli, Laura" uniqKey="Niccoli L" first="Laura" last="Niccoli">Laura Niccoli</name><affiliation><mods:affiliation>2nd Department of Internal Medicine, Rheumatology Unit, Hospital Misericordia e Dolce, Prato, Italy</mods:affiliation></affiliation></author><author><name sortKey="Nannini, Carlotta" sort="Nannini, Carlotta" uniqKey="Nannini C" first="Carlotta" last="Nannini">Carlotta Nannini</name><affiliation><mods:affiliation>2nd Department of Internal Medicine, Rheumatology Unit, Hospital Misericordia e Dolce, Prato, Italy</mods:affiliation></affiliation></author><author><name sortKey="Kaloudi, Olga" sort="Kaloudi, Olga" uniqKey="Kaloudi O" first="Olga" last="Kaloudi">Olga Kaloudi</name><affiliation><mods:affiliation>2nd Department of Internal Medicine, Rheumatology Unit, Hospital Misericordia e Dolce, Prato, Italy</mods:affiliation></affiliation></author><author><name sortKey="Bertoni, Michele" sort="Bertoni, Michele" uniqKey="Bertoni M" first="Michele" last="Bertoni">Michele Bertoni</name><affiliation><mods:affiliation>2nd Department of Internal Medicine, Rheumatology Unit, Hospital Misericordia e Dolce, Prato, Italy</mods:affiliation></affiliation></author><author><name sortKey="Cassara, Emanuele" sort="Cassara, Emanuele" uniqKey="Cassara E" first="Emanuele" last="Cassarà">Emanuele Cassarà</name><affiliation><mods:affiliation>2nd Department of Internal Medicine, Rheumatology Unit, Hospital Misericordia e Dolce, Prato, Italy</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:D5994C6B4CA7C198E4159348AC0F09AAC38EAD6E</idno><date when="2010" year="2010">2010</date><idno type="doi">10.1111/j.1756-185X.2010.01540.x</idno><idno type="url">https://api.istex.fr/document/D5994C6B4CA7C198E4159348AC0F09AAC38EAD6E/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">006412</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">006412</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Psoriatic arthritis: a systematic review</title><author><name sortKey="Cantini, Fabrizio" sort="Cantini, Fabrizio" uniqKey="Cantini F" first="Fabrizio" last="Cantini">Fabrizio Cantini</name><affiliation><mods:affiliation>2nd Department of Internal Medicine, Rheumatology Unit, Hospital Misericordia e Dolce, Prato, Italy</mods:affiliation></affiliation></author><author><name sortKey="Niccoli, Laura" sort="Niccoli, Laura" uniqKey="Niccoli L" first="Laura" last="Niccoli">Laura Niccoli</name><affiliation><mods:affiliation>2nd Department of Internal Medicine, Rheumatology Unit, Hospital Misericordia e Dolce, Prato, Italy</mods:affiliation></affiliation></author><author><name sortKey="Nannini, Carlotta" sort="Nannini, Carlotta" uniqKey="Nannini C" first="Carlotta" last="Nannini">Carlotta Nannini</name><affiliation><mods:affiliation>2nd Department of Internal Medicine, Rheumatology Unit, Hospital Misericordia e Dolce, Prato, Italy</mods:affiliation></affiliation></author><author><name sortKey="Kaloudi, Olga" sort="Kaloudi, Olga" uniqKey="Kaloudi O" first="Olga" last="Kaloudi">Olga Kaloudi</name><affiliation><mods:affiliation>2nd Department of Internal Medicine, Rheumatology Unit, Hospital Misericordia e Dolce, Prato, Italy</mods:affiliation></affiliation></author><author><name sortKey="Bertoni, Michele" sort="Bertoni, Michele" uniqKey="Bertoni M" first="Michele" last="Bertoni">Michele Bertoni</name><affiliation><mods:affiliation>2nd Department of Internal Medicine, Rheumatology Unit, Hospital Misericordia e Dolce, Prato, Italy</mods:affiliation></affiliation></author><author><name sortKey="Cassara, Emanuele" sort="Cassara, Emanuele" uniqKey="Cassara E" first="Emanuele" last="Cassarà">Emanuele Cassarà</name><affiliation><mods:affiliation>2nd Department of Internal Medicine, Rheumatology Unit, Hospital Misericordia e Dolce, Prato, Italy</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">International Journal of Rheumatic Diseases</title><title level="j" type="alt">INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES</title><idno type="ISSN">1756-1841</idno><idno type="eISSN">1756-185X</idno><imprint><biblScope unit="vol">13</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="300">300</biblScope><biblScope unit="page" to="317">317</biblScope><biblScope unit="page-count">18</biblScope><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="2010-10">2010-10</date></imprint><idno type="ISSN">1756-1841</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1756-1841</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Psoriatic arthritis is an inflammatory rheumatic disorder of unknown etiology occurring in patients with psoriasis. The Classification Criteria for Psoriatic Arthritis study group has recently developed a validated set of classification criteria for psoriatic arthritis with a sensitivity of 91.4% and a specificity of 98.7%. Three main clinical patterns have been identified: oligoarticular (≤ 4 involved joints) or polyarticular (≥ 5 involved joints) peripheral disease and axial disease with or without associated peripheral arthritis. In this context distal interphalangeal arthritis and arthritis mutilans may occur. According to other reports, also in our centre, asymmetric oligoarthritis is the most frequent pattern at onset. Axial disease has been estimated between 5% and 36% of patients. It is characterized by an irregular involvement of the axial skeleton with a predilection for the cervical spine. Recurrent episodes of enthesitis and dactylitis represent a hallmark of psoriatic arthritis. In around 20% of cases distal extremity swelling with pitting edema of the hands or feet is observed. Unilateral acute iridocyclitis, usually recurrent in alternate fashion, is the most frequent extra‐articular manifestation, and accelerated atherosclerosis is the prominent comorbidity. The clinical course of peripheral and axial psoriatic arthritis is usually less severe than rheumatoid arthritis and ankylosing spondylitis, respectively. Local corticosteroid injections and non‐steroidal anti‐inflammatory drugs are recommended in milder forms. Sulphasalazine and methotrexate are effective in peripheral psoriatic arthritis. Recent studies have provided evidence on the efficacy of anti‐tumor necrosis factor‐α drugs to control symptoms and to slow or arrest radiological disease progression.</div></front></TEI><istex><corpusName>wiley</corpusName><keywords><teeft><json:string>psoriatic</json:string><json:string>psoriatic arthritis</json:string><json:string>rheumatol</json:string><json:string>psoriasis</json:string><json:string>arthritis</json:string><json:string>rheum</json:string><json:string>arthritis rheum</json:string><json:string>dactylitis</json:string><json:string>enthesitis</json:string><json:string>spondylitis</json:string><json:string>cantini</json:string><json:string>rheumatology</json:string><json:string>rheumatoid</json:string><json:string>gladman</json:string><json:string>rheumatic diseases</json:string><json:string>ankylosing</json:string><json:string>olivieri</json:string><json:string>international journal</json:string><json:string>clin</json:string><json:string>tendon</json:string><json:string>synovitis</json:string><json:string>sacroiliitis</json:string><json:string>salvarani</json:string><json:string>rheumatoid arthritis</json:string><json:string>ankylosing spondylitis</json:string><json:string>mease</json:string><json:string>synovial</json:string><json:string>seronegative</json:string><json:string>spondyloarthropathies</json:string><json:string>helliwell</json:string><json:string>cytokine</json:string><json:string>radiological</json:string><json:string>sapho</json:string><json:string>dermatol</json:string><json:string>ultrasound</json:string><json:string>atherosclerosis</json:string><json:string>articular</json:string><json:string>arthritis mutilans</json:string><json:string>mutilans</json:string><json:string>interphalangeal</json:string><json:string>axial</json:string><json:string>subset</json:string><json:string>semin arthritis rheum</json:string><json:string>spondyloarthropathy</json:string><json:string>padula</json:string><json:string>semin</json:string><json:string>spondyloarthritis</json:string><json:string>adalimumab</json:string><json:string>biologics</json:string><json:string>axial disease</json:string><json:string>edema</json:string><json:string>clinical features</json:string><json:string>psoriatic patients</json:string><json:string>rheumatic</json:string><json:string>insertion</json:string><json:string>digit</json:string><json:string>sapho syndrome</json:string><json:string>symmetrical synovitis</json:string><json:string>distal extremity</json:string><json:string>clin rheumatol</json:string><json:string>subclinical atherosclerosis</json:string><json:string>imaging</json:string><json:string>prevalence</json:string><json:string>family history</json:string><json:string>caspar criteria</json:string><json:string>american college</json:string><json:string>curr rheumatol</json:string><json:string>frequent pattern</json:string><json:string>skin disease</json:string><json:string>clinical aspects</json:string><json:string>magnetic resonance imaging</json:string><json:string>articular involvement</json:string><json:string>cervical spine</json:string><json:string>several studies</json:string><json:string>clinical examination</json:string><json:string>reactive arthritis</json:string><json:string>peripheral arthritis</json:string><json:string>early psoriatic arthritis</json:string><json:string>rheumatoid factor</json:string><json:string>recent studies</json:string><json:string>disease activity</json:string><json:string>clinical expression</json:string><json:string>psoriatic arthritis patients</json:string><json:string>tumor necrosis factor</json:string><json:string>syndrome</json:string></teeft></keywords><author><json:item><name>Fabrizio CANTINI</name><affiliations><json:string>2nd Department of Internal Medicine, Rheumatology Unit, Hospital Misericordia e Dolce, Prato, Italy</json:string></affiliations></json:item><json:item><name>Laura NICCOLI</name><affiliations><json:string>2nd Department of Internal Medicine, Rheumatology Unit, Hospital Misericordia e Dolce, Prato, Italy</json:string></affiliations></json:item><json:item><name>Carlotta NANNINI</name><affiliations><json:string>2nd Department of Internal Medicine, Rheumatology Unit, Hospital Misericordia e Dolce, Prato, Italy</json:string></affiliations></json:item><json:item><name>Olga KALOUDI</name><affiliations><json:string>2nd Department of Internal Medicine, Rheumatology Unit, Hospital Misericordia e Dolce, Prato, Italy</json:string></affiliations></json:item><json:item><name>Michele BERTONI</name><affiliations><json:string>2nd Department of Internal Medicine, Rheumatology Unit, Hospital Misericordia e Dolce, Prato, Italy</json:string></affiliations></json:item><json:item><name>Emanuele CASSARÀ</name><affiliations><json:string>2nd Department of Internal Medicine, Rheumatology Unit, Hospital Misericordia e Dolce, Prato, Italy</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>anti‐TNF</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>classification criteria</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>dactylitis</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>enthesitis</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>psoriatic arthritis</value></json:item></subject><articleId><json:string>APL1540</json:string></articleId><language><json:string>eng</json:string></language><originalGenre><json:string>reviewArticle</json:string></originalGenre><abstract>Psoriatic arthritis is an inflammatory rheumatic disorder of unknown etiology occurring in patients with psoriasis. The Classification Criteria for Psoriatic Arthritis study group has recently developed a validated set of classification criteria for psoriatic arthritis with a sensitivity of 91.4% and a specificity of 98.7%. Three main clinical patterns have been identified: oligoarticular (≤ 4 involved joints) or polyarticular (≥ 5 involved joints) peripheral disease and axial disease with or without associated peripheral arthritis. In this context distal interphalangeal arthritis and arthritis mutilans may occur. According to other reports, also in our centre, asymmetric oligoarthritis is the most frequent pattern at onset. Axial disease has been estimated between 5% and 36% of patients. It is characterized by an irregular involvement of the axial skeleton with a predilection for the cervical spine. Recurrent episodes of enthesitis and dactylitis represent a hallmark of psoriatic arthritis. In around 20% of cases distal extremity swelling with pitting edema of the hands or feet is observed. Unilateral acute iridocyclitis, usually recurrent in alternate fashion, is the most frequent extra‐articular manifestation, and accelerated atherosclerosis is the prominent comorbidity. The clinical course of peripheral and axial psoriatic arthritis is usually less severe than rheumatoid arthritis and ankylosing spondylitis, respectively. Local corticosteroid injections and non‐steroidal anti‐inflammatory drugs are recommended in milder forms. Sulphasalazine and methotrexate are effective in peripheral psoriatic arthritis. Recent studies have provided evidence on the efficacy of anti‐tumor necrosis factor‐α drugs to control symptoms and to slow or arrest radiological disease progression.</abstract><qualityIndicators><score>7.94</score><pdfVersion>1.3</pdfVersion><pdfPageSize>595.276 x 779.528 pts</pdfPageSize><refBibsNative>true</refBibsNative><abstractCharCount>1805</abstractCharCount><pdfWordCount>9594</pdfWordCount><pdfCharCount>64942</pdfCharCount><pdfPageCount>18</pdfPageCount><abstractWordCount>245</abstractWordCount></qualityIndicators><title>Psoriatic arthritis: a systematic review</title><genre><json:string>review-article</json:string></genre><host><title>International Journal of Rheumatic Diseases</title><language><json:string>unknown</json:string></language><doi><json:string>10.1111/(ISSN)1756-185X</json:string></doi><issn><json:string>1756-1841</json:string></issn><eissn><json:string>1756-185X</json:string></eissn><publisherId><json:string>APL</json:string></publisherId><volume>13</volume><issue>4</issue><pages><first>300</first><last>317</last><total>18</total></pages><genre><json:string>journal</json:string></genre></host><categories><wos><json:string>science</json:string><json:string>rheumatology</json:string></wos><scienceMetrix></scienceMetrix><inist><json:string>sciences appliquees, technologies et medecines</json:string><json:string>sciences biologiques et medicales</json:string><json:string>sciences medicales</json:string></inist></categories><publicationDate>2010</publicationDate><copyrightDate>2010</copyrightDate><doi><json:string>10.1111/j.1756-185X.2010.01540.x</json:string></doi><id>D5994C6B4CA7C198E4159348AC0F09AAC38EAD6E</id><score>1</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/document/D5994C6B4CA7C198E4159348AC0F09AAC38EAD6E/fulltext/pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/document/D5994C6B4CA7C198E4159348AC0F09AAC38EAD6E/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/D5994C6B4CA7C198E4159348AC0F09AAC38EAD6E/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main">Psoriatic arthritis: a systematic review</title></titleStmt><publicationStmt><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><availability><licence>© 2010 Asia Pacific League of Associations for Rheumatology and Blackwell Publishing Asia Pty Ltd</licence></availability><date type="published" when="2010-10"></date></publicationStmt><notesStmt><note type="content-type" subtype="review-article" source="reviewArticle" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-L5L7X3NF-P">review-article</note><note type="publication-type" subtype="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note></notesStmt><sourceDesc><biblStruct type="review-article"><analytic><title level="a" type="main">Psoriatic arthritis: a systematic review</title><title level="a" type="short">PsA review</title><author xml:id="author-0000"><persName><forename type="first">Fabrizio</forename><surname>CANTINI</surname></persName><affiliation>2nd Department of Internal Medicine, Rheumatology Unit, Hospital Misericordia e Dolce, Prato, Italy<address><country key="IT"></country></address></affiliation></author><author xml:id="author-0001"><persName><forename type="first">Laura</forename><surname>NICCOLI</surname></persName><affiliation>2nd Department of Internal Medicine, Rheumatology Unit, Hospital Misericordia e Dolce, Prato, Italy<address><country key="IT"></country></address></affiliation></author><author xml:id="author-0002"><persName><forename type="first">Carlotta</forename><surname>NANNINI</surname></persName><affiliation>2nd Department of Internal Medicine, Rheumatology Unit, Hospital Misericordia e Dolce, Prato, Italy<address><country key="IT"></country></address></affiliation></author><author xml:id="author-0003"><persName><forename type="first">Olga</forename><surname>KALOUDI</surname></persName><affiliation>2nd Department of Internal Medicine, Rheumatology Unit, Hospital Misericordia e Dolce, Prato, Italy<address><country key="IT"></country></address></affiliation></author><author xml:id="author-0004"><persName><forename type="first">Michele</forename><surname>BERTONI</surname></persName><affiliation>2nd Department of Internal Medicine, Rheumatology Unit, Hospital Misericordia e Dolce, Prato, Italy<address><country key="IT"></country></address></affiliation></author><author xml:id="author-0005"><persName><forename type="first">Emanuele</forename><surname>CASSARÀ</surname></persName><affiliation>2nd Department of Internal Medicine, Rheumatology Unit, Hospital Misericordia e Dolce, Prato, Italy<address><country key="IT"></country></address></affiliation></author><idno type="istex">D5994C6B4CA7C198E4159348AC0F09AAC38EAD6E</idno><idno type="DOI">10.1111/j.1756-185X.2010.01540.x</idno><idno type="unit">APL1540</idno><idno type="toTypesetVersion">file:APL.APL1540.pdf</idno></analytic><monogr><title level="j" type="main">International Journal of Rheumatic Diseases</title><title level="j" type="alt">INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES</title><idno type="pISSN">1756-1841</idno><idno type="eISSN">1756-185X</idno><idno type="book-DOI">10.1111/(ISSN)1756-185X</idno><idno type="book-part-DOI">10.1111/apl.2010.13.issue-4</idno><idno type="product">APL</idno><idno type="publisherDivision">ST</idno><imprint><biblScope unit="vol">13</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="300">300</biblScope><biblScope unit="page" to="317">317</biblScope><biblScope unit="page-count">18</biblScope><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="2010-10"></date></imprint></monogr></biblStruct></sourceDesc></fileDesc><profileDesc><abstract xml:lang="en" style="main"><head>Abstract</head><p>Psoriatic arthritis is an inflammatory rheumatic disorder of unknown etiology occurring in patients with psoriasis. The Classification Criteria for Psoriatic Arthritis study group has recently developed a validated set of classification criteria for psoriatic arthritis with a sensitivity of 91.4% and a specificity of 98.7%. Three main clinical patterns have been identified: oligoarticular (≤ 4 involved joints) or polyarticular (≥ 5 involved joints) peripheral disease and axial disease with or without associated peripheral arthritis. In this context distal interphalangeal arthritis and arthritis mutilans may occur. According to other reports, also in our centre, asymmetric oligoarthritis is the most frequent pattern at onset. Axial disease has been estimated between 5% and 36% of patients. It is characterized by an irregular involvement of the axial skeleton with a predilection for the cervical spine. Recurrent episodes of enthesitis and dactylitis represent a hallmark of psoriatic arthritis. In around 20% of cases distal extremity swelling with pitting edema of the hands or feet is observed. Unilateral acute iridocyclitis, usually recurrent in alternate fashion, is the most frequent extra‐articular manifestation, and accelerated atherosclerosis is the prominent comorbidity. The clinical course of peripheral and axial psoriatic arthritis is usually less severe than rheumatoid arthritis and ankylosing spondylitis, respectively. Local corticosteroid injections and non‐steroidal anti‐inflammatory drugs are recommended in milder forms. Sulphasalazine and methotrexate are effective in peripheral psoriatic arthritis. Recent studies have provided evidence on the efficacy of anti‐tumor necrosis factor‐α drugs to control symptoms and to slow or arrest radiological disease progression.</p></abstract><textClass><keywords xml:lang="en"><term xml:id="k1">anti‐TNF</term><term xml:id="k2">classification criteria</term><term xml:id="k3">dactylitis</term><term xml:id="k4">enthesitis</term><term xml:id="k5">psoriatic arthritis</term></keywords><classCode scheme="tocHeading1">Review articles</classCode></textClass><langUsage><language ident="EN"></language></langUsage></profileDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/document/D5994C6B4CA7C198E4159348AC0F09AAC38EAD6E/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Blackwell Publishing Ltd</publisherName><publisherLoc>Oxford, UK</publisherLoc></publisherInfo><doi origin="wiley" registered="yes">10.1111/(ISSN)1756-185X</doi><issn type="print">1756-1841</issn><issn type="electronic">1756-185X</issn><idGroup><id type="product" value="APL"></id><id type="publisherDivision" value="ST"></id></idGroup><titleGroup><title type="main" sort="INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES">International Journal of Rheumatic Diseases</title></titleGroup></publicationMeta><publicationMeta level="part" position="10104"><doi origin="wiley">10.1111/apl.2010.13.issue-4</doi><numberingGroup><numbering type="journalVolume" number="13">13</numbering><numbering type="journalIssue" number="4">4</numbering></numberingGroup><coverDate startDate="2010-10">October 2010</coverDate></publicationMeta><publicationMeta level="unit" type="reviewArticle" position="5" status="forIssue"><doi origin="wiley">10.1111/j.1756-185X.2010.01540.x</doi><idGroup><id type="unit" value="APL1540"></id></idGroup><countGroup><count type="pageTotal" number="18"></count></countGroup><titleGroup><title type="tocHeading1">Review articles</title></titleGroup><copyright>© 2010 Asia Pacific League of Associations for Rheumatology and Blackwell Publishing Asia Pty Ltd</copyright><eventGroup><event type="firstOnline" date="2010-06-10"></event><event type="publishedOnlineFinalForm" date="2010-06-10"></event><event type="xmlConverted" agent="Converter:BPG_TO_WML3G version:2.3.22 mode:FullText" date="2010-10-05"></event><event type="publishedOnlineEarlyUnpaginated" date="2010-06-10"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-01-04"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-24"></event></eventGroup><numberingGroup><numbering type="pageFirst" number="300">300</numbering><numbering type="pageLast" number="317">317</numbering></numberingGroup><correspondenceTo>Fabrizio Cantini, 2nd Department of Internal Medicine‐Rheumatology Unit, Hospital of Prato, Piazza Ospedale, 1, 59100 – Prato, Italy. Email: <email>fcantini@usl4.toscana.it</email> (workplace address); <email>fbrzcantini@gmail.com</email> (home address).</correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:APL.APL1540.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="figureTotal" number="4"></count><count type="tableTotal" number="5"></count></countGroup><titleGroup><title type="main">Psoriatic arthritis: a systematic review</title><title type="shortAuthors">F. Cantini <i>et al.</i></title><title type="short">PsA review</title></titleGroup><creators><creator creatorRole="author" xml:id="cr1" affiliationRef="#aff-1-1"><personName><givenNames>Fabrizio</givenNames><familyName>CANTINI</familyName></personName></creator><creator creatorRole="author" xml:id="cr2" affiliationRef="#aff-1-1"><personName><givenNames>Laura</givenNames><familyName>NICCOLI</familyName></personName></creator><creator creatorRole="author" xml:id="cr3" affiliationRef="#aff-1-1"><personName><givenNames>Carlotta</givenNames><familyName>NANNINI</familyName></personName></creator><creator creatorRole="author" xml:id="cr4" affiliationRef="#aff-1-1"><personName><givenNames>Olga</givenNames><familyName>KALOUDI</familyName></personName></creator><creator creatorRole="author" xml:id="cr5" affiliationRef="#aff-1-1"><personName><givenNames>Michele</givenNames><familyName>BERTONI</familyName></personName></creator><creator creatorRole="author" xml:id="cr6" affiliationRef="#aff-1-1"><personName><givenNames>Emanuele</givenNames><familyName>CASSARÀ</familyName></personName></creator></creators><affiliationGroup><affiliation xml:id="aff-1-1" countryCode="IT"><unparsedAffiliation>2nd Department of Internal Medicine, Rheumatology Unit, Hospital Misericordia e Dolce, Prato, Italy</unparsedAffiliation></affiliation></affiliationGroup><keywordGroup xml:lang="en"><keyword xml:id="k1">anti‐TNF</keyword><keyword xml:id="k2">classification criteria</keyword><keyword xml:id="k3">dactylitis</keyword><keyword xml:id="k4">enthesitis</keyword><keyword xml:id="k5">psoriatic arthritis</keyword></keywordGroup><abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title><p>Psoriatic arthritis is an inflammatory rheumatic disorder of unknown etiology occurring in patients with psoriasis. The Classification Criteria for Psoriatic Arthritis study group has recently developed a validated set of classification criteria for psoriatic arthritis with a sensitivity of 91.4% and a specificity of 98.7%. Three main clinical patterns have been identified: oligoarticular (≤ 4 involved joints) or polyarticular (≥ 5 involved joints) peripheral disease and axial disease with or without associated peripheral arthritis. In this context distal interphalangeal arthritis and arthritis mutilans may occur. According to other reports, also in our centre, asymmetric oligoarthritis is the most frequent pattern at onset. Axial disease has been estimated between 5% and 36% of patients. It is characterized by an irregular involvement of the axial skeleton with a predilection for the cervical spine. Recurrent episodes of enthesitis and dactylitis represent a hallmark of psoriatic arthritis. In around 20% of cases distal extremity swelling with pitting edema of the hands or feet is observed. Unilateral acute iridocyclitis, usually recurrent in alternate fashion, is the most frequent extra‐articular manifestation, and accelerated atherosclerosis is the prominent comorbidity. The clinical course of peripheral and axial psoriatic arthritis is usually less severe than rheumatoid arthritis and ankylosing spondylitis, respectively. Local corticosteroid injections and non‐steroidal anti‐inflammatory drugs are recommended in milder forms. Sulphasalazine and methotrexate are effective in peripheral psoriatic arthritis. Recent studies have provided evidence on the efficacy of anti‐tumor necrosis factor‐α drugs to control symptoms and to slow or arrest radiological disease progression.</p></abstract></abstractGroup></contentMeta></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Psoriatic arthritis: a systematic review</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>PsA review</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Psoriatic arthritis: a systematic review</title></titleInfo><name type="personal"><namePart type="given">Fabrizio</namePart><namePart type="family">CANTINI</namePart><affiliation>2nd Department of Internal Medicine, Rheumatology Unit, Hospital Misericordia e Dolce, Prato, Italy</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Laura</namePart><namePart type="family">NICCOLI</namePart><affiliation>2nd Department of Internal Medicine, Rheumatology Unit, Hospital Misericordia e Dolce, Prato, Italy</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Carlotta</namePart><namePart type="family">NANNINI</namePart><affiliation>2nd Department of Internal Medicine, Rheumatology Unit, Hospital Misericordia e Dolce, Prato, Italy</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Olga</namePart><namePart type="family">KALOUDI</namePart><affiliation>2nd Department of Internal Medicine, Rheumatology Unit, Hospital Misericordia e Dolce, Prato, Italy</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Michele</namePart><namePart type="family">BERTONI</namePart><affiliation>2nd Department of Internal Medicine, Rheumatology Unit, Hospital Misericordia e Dolce, Prato, Italy</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Emanuele</namePart><namePart type="family">CASSARÀ</namePart><affiliation>2nd Department of Internal Medicine, Rheumatology Unit, Hospital Misericordia e Dolce, Prato, Italy</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="review-article" displayLabel="reviewArticle"></genre><originInfo><publisher>Blackwell Publishing Ltd</publisher><place><placeTerm type="text">Oxford, UK</placeTerm></place><dateIssued encoding="w3cdtf">2010-10</dateIssued><copyrightDate encoding="w3cdtf">2010</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="figures">4</extent><extent unit="tables">5</extent></physicalDescription><abstract lang="en">Psoriatic arthritis is an inflammatory rheumatic disorder of unknown etiology occurring in patients with psoriasis. The Classification Criteria for Psoriatic Arthritis study group has recently developed a validated set of classification criteria for psoriatic arthritis with a sensitivity of 91.4% and a specificity of 98.7%. Three main clinical patterns have been identified: oligoarticular (≤ 4 involved joints) or polyarticular (≥ 5 involved joints) peripheral disease and axial disease with or without associated peripheral arthritis. In this context distal interphalangeal arthritis and arthritis mutilans may occur. According to other reports, also in our centre, asymmetric oligoarthritis is the most frequent pattern at onset. Axial disease has been estimated between 5% and 36% of patients. It is characterized by an irregular involvement of the axial skeleton with a predilection for the cervical spine. Recurrent episodes of enthesitis and dactylitis represent a hallmark of psoriatic arthritis. In around 20% of cases distal extremity swelling with pitting edema of the hands or feet is observed. Unilateral acute iridocyclitis, usually recurrent in alternate fashion, is the most frequent extra‐articular manifestation, and accelerated atherosclerosis is the prominent comorbidity. The clinical course of peripheral and axial psoriatic arthritis is usually less severe than rheumatoid arthritis and ankylosing spondylitis, respectively. Local corticosteroid injections and non‐steroidal anti‐inflammatory drugs are recommended in milder forms. Sulphasalazine and methotrexate are effective in peripheral psoriatic arthritis. Recent studies have provided evidence on the efficacy of anti‐tumor necrosis factor‐α drugs to control symptoms and to slow or arrest radiological disease progression.</abstract><subject lang="en"><genre>keywords</genre><topic>anti‐TNF</topic><topic>classification criteria</topic><topic>dactylitis</topic><topic>enthesitis</topic><topic>psoriatic arthritis</topic></subject><relatedItem type="host"><titleInfo><title>International Journal of Rheumatic Diseases</title></titleInfo><genre type="journal">journal</genre><identifier type="ISSN">1756-1841</identifier><identifier type="eISSN">1756-185X</identifier><identifier type="DOI">10.1111/(ISSN)1756-185X</identifier><identifier type="PublisherID">APL</identifier><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>13</number></detail><detail type="issue"><caption>no.</caption><number>4</number></detail><extent unit="pages"><start>300</start><end>317</end><total>18</total></extent></part></relatedItem><identifier type="istex">D5994C6B4CA7C198E4159348AC0F09AAC38EAD6E</identifier><identifier type="DOI">10.1111/j.1756-185X.2010.01540.x</identifier><identifier type="ArticleID">APL1540</identifier><accessCondition type="use and reproduction" contentType="copyright">© 2010 Asia Pacific League of Associations for Rheumatology and Blackwell Publishing Asia Pty Ltd</accessCondition><recordInfo><recordContentSource>WILEY</recordContentSource><recordOrigin>Blackwell Publishing Ltd</recordOrigin></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006412 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 006412 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:D5994C6B4CA7C198E4159348AC0F09AAC38EAD6E
|texte= Psoriatic arthritis: a systematic review
}}
| This area was generated with Dilib version V0.6.31. |  |